N-(Phosphonacetyl)-l-aspartate (PALA) in advanced malignant melanoma: A phase II trial of the EORTC malignant melanoma cooperative group
- 1 August 1982
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 18 (8), 723-726
- https://doi.org/10.1016/0277-5379(82)90069-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- N-(Phosphonacetyl)-l-aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC soft tissue sarcoma groupEuropean Journal of Cancer and Clinical Oncology, 1982
- N-(Phosphonacetyl)-l-aspartate (PALA) in advanced breast cancer: a phase II trial of the EORTC breast cancer cooperative groupEuropean Journal of Cancer and Clinical Oncology, 1982
- PHARMACOLOGICAL DISPOSITION OF N-(PHOSPHONACETYL)-L-ASPARTATE IN HUMANS1980
- PHASE-I CLINICAL-STUDY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA)1980
- PHASE-I TRIAL OF N-(PHOSPHONACETYL)-L-ASPARTATE1979
- PHASE-I STUDY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA)1979
- MECHANISMS OF SENSITIVITY OR RESISTANCE OF MURINE TUMORS TO N-(PHOSPHONACETYL)-L-ASPARTATE (PALA)1979
- EFFECTS OF N-(PHOSPHONACETYL)-L-ASPARTATE ON MURINE TUMORS AND NORMAL TISSUES INVIVO AND INVITRO AND RELATIONSHIP OF SENSITIVITY TO RATE OF PROLIFERATION AND LEVEL OF ASPARTATE-TRANSCARBAMYLASE1978
- Reversal of toxicity and antitumor activity of N-(phosphonacetyl)-L-aspartate by uridine or carbamyl-DL-aspartate in vivoBiochemical Pharmacology, 1977
- Stable mutants of mammalian cells that overproduce the first three enzymes of pyrimidine nucleotide biosynthesisCell, 1976